NECROTIZING FASCIITIS AT THE EXTREMITIES AND ITS MANAGEMENT


Necrotizing fasciitis at the extremities and its management


Hatim ABID1*, Mohammed EL IDRISSI1, Abdelhalim EL IBRAHIMI1, Abdelmajid ELMRINI1, Nissrine AMRAOUI2, Sara ELLOUDI2, Hanane BAYBAY2, Fatima Zahra Mernissi2

1Department of osteoarticular surgery B4, HASSAN II teaching hospital, Fes, Morocco.
2Department of dermatology HASSAN II teaching hospital, Fes, Morocco.


We report in the light of a literature review the results of 28 patients treated for Necrotizing Fasciitis (NF) at the extremities between 2012 and 2017 with a view to a prospective study with longer following up and a greater number of patients.


Keywords: Necrotizing Fasciitis; extremities; treatment

Free Full-text PDF


How to cite this article:
Hatim ABID, Mohammed EL IDRISSI, Abdelhalim EL IBRAHIMI , Abdelmajid ELMRINI,Nissrine AMRAOUI, Sara ELLOUDI, Hanane BAYBAY, Fatima Zahra Mernissi. Necrotizing fasciitis at the extremities and its management.American Journal of Dermatological Research and Reviews, 2021; 4:45. DOI: 10.28933/ajodrr-2021-06-0106


References:

1. Wilson B. Necrotizing fasciitis. Am Surg. 1952;18:416-31.
2. Bellapianta JM, Ljungquist K, Tobin E, et al. Ne-crotizing fasciitis. J Am Acad Orthop Surg. 2009;17:174-82.
3. Misiakos EP, Bagias G, Patapis P, Sotiropoulos D, Kanavidis P, Machairas A. Current concepts in the management of necrotizing fasciitis. Front Surg. 2014;1:36.
4. Bharathan R, Hanson M. Diagnostic laparoscopy complicated by group A strep- tococcal necroti-zing fasciitis. J Minim Invasive Gynecol. 2010;17(1):121-3.
5. Tang S, Kwok TK, Ho PL. Necrotising fasciitis in renal transplant recipient with FK506: the first reported case. Clin Nephrol. 2002;56:481-5.
6. Hansen SL, Mathes SJ, Young DM. Skin and subcutaneous tissue. In : Schwartz Principles of Surgery. 8th edition. McGraw Hill. 2005;429-52.
7. Hoeffel JC, Hoeffel F. Necrotising fasciitis and purpuras fulminants. Plast Recon Surg. 2002;109:2165.
8. Kilic A, Aksoy Y, Kilic A. Fournier’s gangrene: Etiology, treatment and complications. Ann Plast Surg. 2001;47:523-7.
9. Kotrappa KS, Bansal RS, Amin NM. Necrotising fasciitis. Am Fam Phy. 1996;53(53):1691-6.
10. Fazeli M, Keramati MR. Necrotising fasciitis an epidemiological study of 102 cases. Indian J Surg. 2007;69:136-9.
11. Corman ML. Infectious conditions in Colon and Rectal surgery; 4th edition; Lippincot Raven. 1998;513-515.
12. Cai Y, Gan Y, Yu C, Tang J, Sun Y. A successful treatment of necrotizing fasciitis following the surgery of distal radius plate removal: A case report and literature review. Medicine. 2018; 97(15):e0305.
13. Hung TH, Tsai CC, Tsai CC. Liver cirrhosis as a real risk factor for necrotizing fasciitis: a three tear population based follow study. Singapore Med J. 2014;55:378-82
14. Tung-Yiu W, Jehn-Shyun H, Ching-Hung C, Hung-An C. Cervical necrotizing fasciitis of odontogenic origin: a report of 11 cases. J Oral Maxillofac Surg. 2000;58(12):1347-52.
15. Federman DG, Kravetz JD, Kirsner RS. Necroti-zing fasciitis and cardiac catheterization. Cutis. 2004;73(1):49-52.
16. Murari A, Singh K N. Lund and Browder chart – modified versus original : a comparative study. Acute Crit Care. 2019; 34(4):276-281.
17. Kaul R, McGeer A, Low DE, Green K, Schwartz B. Population based surveillance for group A streptococcal necrotizing fasciitis: clinical fea-tures, prognostic indicators, and microbio- logic analysis of seventy-seven cases. Ontario Group A Streptococcal Study. Am J Med. 1997;103:18–24.
18. Levine EG, Manders SM. Life-threatening necro-tizing fasciitis. Clin Dermatol. 2005;23:144–7.
19. Goh T, Goh LG, Ang CH, Wong CH. Early dia-gnosis of necrotizing fasciitis. Br J Surg. 2014;101:119–25.
20. Anaya DA, Dellinger EP. Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis. 2007;44:705–10.
21. Anaya DA, McMahon K, Nathens AB. Predictors of mortality and limb loss in necrotizing soft tis-sue infections. Arch Surg. 2005;140:151–7.
22. Espandar R, Sibdari SY, Rafiee E, Yazdanian S. Necrotizing fasciitis of the extremities a prospec-tive study. Strategies Trauma Limb Reconstr. 2011;6:121–5.
23. Sarani B, Strong M, Pascual J, Schwab CW. Ne-crotizing Fasciitis: Current Concepts and Review of the Literature. j am coll surg.2008. 208(2):279-288.
24. McHenry CR, Piotrowski JJ, Petrinic D, Malangoni MA. Determinants of mortality for necrotizing soft-tissue infections. Ann Surg.1995;221:558–563.
25. Wong CH, Haw-Chong C, Shanker P, et al. Ne-crotizing fasciitis: clinical presentation, micro-biology, and determinants of mortality. J Bone Joint Surg Am. 2003;85:1454–1460.
26. Freischlag JA, Ajalat G, Busuttil RW. Treatment of necrotizing soft tissue infections. The need for a new approach. Am J Surg.1985;149:751–755.
27. Childers BJ, Potyondy LD, Nachreiner R, et al. Necrotizing fasciitis: a fourteen-year retrospec- tive study of 163 consecutive patients. Am Surg. 2002;68:109–116.
28. Miller LG, Perdreau-Remington F, Rieg G, et al. Necrotizing fasciitis caused by communi-ty-associated methicillin-resistant Staphylococ-cus aureus in Los Angeles. N Engl J Med. 2005;352:1445–1453.
29. Maltezou HC, Giamarellou H. Community-acquired methicillin resistant Staphylococcus aureus in-fections. Int J Antimicrob Agents. 2006;27:87–96.
30. Thulin P, Johansson L, Low DE, et al. Viable group A strepto cocci in macrophages during acute soft tissue infection. PLoS Med. 2006;3:e53.
31. Reid SD, Chaussee MS, Doern CD, et al. Inacti-vation of the group A Streptococcus regulator srv results in chromosome wide reduction of trans-cript levels, and changes in ex-
a. tracellular levels of Sic and SpeB. FEMS Immu-
b. nol Med Microbiol. 2006;48:283–292.
32. Howard R, Pessa M, Brennaman B, Ramphal R. Necrotizing soft-tissue infections caused by ma-rine vibrios. Surgery. 1985;98:126–130.
33. Salcido RS. Necrotizing fasciitis: reviewing the causes and treatment strategies. Adv Skin Wound Care. 2007;20:288–293.
34. Cainzos M, Gonzalez-Rodriguez FJ. Necrotizing soft tissue infections. Curr Opin Crit Care. 2007;13:433–4.
35. Huang KF, Hung MH, Lin YS, Lu CL, Liu C, Chen CC, et al. Independent predictors of mortality for necrotizing fasciitis: a retrospective analysis in a single institution. J Trauma. 2011;71:467–73.
36. Morgan MS. Diagnosis and management of ne-crotising fasciitis: a multiparametric approach. J Hosp Infect. 2010;75:249–57.
37. Roje Z, Roje Z, Matic D, Librenjak D, Dokuzovic S, Varvodic J. Necrotizing fasciitis: literature re-view of contemporary strategies for diagnosing and management with three case reports: torso, abdominal wall, upper and lower limbs. Word J Emerg Surg. 2011;23(6):46.
38. Martinschek A, Evers B, Lampl L, Gerngroß H, Schmidt R, Sparwasser C. Prognostic aspects, survival rate, and predisposing risk factors in pa-tients with Fournier’s gangrene and necrotizing soft tissue infections: evaluation of clinical out-come of 55 patients. Urol Int. 2012; 89:173–9.
39. eung YK, Ho ST, Yen CH, Ho PC, Tse WL, Lau YK, et al. Wong factors affecting mortality in Hong Kong patients with upper limb necrotising fascii-tis. Hong Kong Med J. 2011;17:96–104.
40. Sarani B, Strong M, Pascual J, Schwab CW. Ne-crotizing Fasciitis: Current Concepts and Review of the Literature. j am coll surg.2008; 208(2):279-288.
41. Shimizu T, Tokuda Y. Necrotizing fasciitis. Intern Med. 2010;49:1051–7.
42. Frazee BW, Fee C, Lynn J, Wang R, Bostrom A, Hargis C, et al. Community acquired necrotizing soft tissue infections: a review of 122 cases presenting to a single emergency department over 12 years. J Emerg Med. (2008); 34:139–46.
43. Wong C, Khin L. Clinical relevance of the LRINEC (laboratory risk indicator for necrotizing fasciitis) score for assessment of early necrotizing fascii-tis. Crit Care Med. 2005; 33:1677.
44. Majeski JA, Alexander JW. Early diagnosis, nu-trition support, and immediate extensive debri-dement improve survival necrotizing fasciitis. Am J Surg.1983;145:785–7.
45. Wong CH, Khin LW, Heng KS, Tan KC, Low CO. The LRINEC (laboratory risk indicator for necroti-zing fasciitis) score: a tool for distinguishing ne-crotizing fasciitis from other soft tissue infec-tions.
46. C Bechar J, Sepehripour S, Hardwicke J, Filobbos G. Laboratory risk indicator for necrotising fas-ciitis (LRINEC) score for the assessment of early necrotising fasciitis: a systematic review of the literature. Ann R Coll Surg Engl. 2017; 99: 341–346.rit Care Med. 2004;32:1535–41.
47. Thomas AJ, Meyer TK. Retrospective evaluation of laboratory-based diagnostic tools for cervical necrotizing fasciitis. Laryngoscope. 2012;122: 2683–7.
48. Borschitz T, Schlicht S, Siegel E, Hanke E, von Stebut E. Improvement of a clinical score for necrotizing fasciitis:‘pain outof proportion’and high CRP levels aid the diagnosis. PLoS One. 2015;10(7): e0132775.
49. Sertoglu E, Uyanik M, Kayadibi H. Is red blood cell distribution width enough to predict prognosis of necrotizing fasciitis. Am J Emerg Med. 2015;33(2): 301-2.
50. Murphy G, Markeson D, Choa R, Armstrong A. Raised serum lactate: a marker of necrotizing fasciitis. J Plast Reconstr Aesthet Surg. 2013;66(12): 1712-6.
51. Ruiz-Tovar J, Córdoba L, Devesa JM. Prognostic factors in Fournier gangrene. Asian J Surg. 2012;35:37–41.
52. Nagano N, Isomine S, Kato H, Sasaki Y, Ta-kahashi M, Sakaida K, et al. Human fulminant gas gangrene caused by Clostridium chauvoei. J Clin Microbiol. 2008;46:1545–7.
53. Schmid MR, Kossmann T, Duewell S. Differen-tiation of necrotizing fasciitis and cellulitis using MR imaging. AJR Am J Roentgenol. 1998;170:615–620.
54. Hopkins KL, Li KC, Bergman G. Gadolinium-DTPA enhanced magnetic resonance imaging of mus-culoskeletal infectious processes. Skeletal Ra-diol. 1995;24:325–330.
55. Majeski J, Majeski E. Necrotizing fasciitis: im-proved survival with early recognition by tissue biopsy and aggressive surgical treatment. South Med J. 1997;90:1065–1068.
56. Stamenkovic I, Lew P. Early recognition of po-tentially fatal necrotizing fasciitis: the use of frozen section biopsy. N Engl J Med. 1984; 310:1689–1693.
57. Kalaivani V, Hiremath BV, Indumathi VA. Necroti-sing soft tissue infection-risk factors for mortality. J Clin Diagn Res. 2013;7:1662–5.
58. Wong KC, Shih CH. Necrotizing fasciitis of the extremities. J Trauma.1992;32:179–82.
59. Chen JL, Fullerton KE, Flynn NM. Necrotizing. fasciitis associated with injection drug use. Clin Infect Dis. 2001;33:6–15.
60. Elliott DC, Kufera JA, Myers RA. Necrotizing soft tissue infections. Risk factors for mortality and strategies for management. Ann Surg. 1996;224:672–683.
61. Huang WS, Hsieh SC, Hsieh CS, et al. Use of vacuum-assisted wound closure to manage limb wounds in patients suffering from acute necroti-zing fasciitis. Asian J Surg. 2006;29:135–139.
62. Moues CM, Vos MC, van den Bemd GJ, et al. Bacterial load in relation to vacuum-assisted closure wound therapy: a prospective randomized trial. Wound Repair Regen. 2004;12:11.
63. Naqvi GA, Malik SA, Jan W. Necrotizing fasciitis of the lower extremity: a case report and current concept of diagnoses and management. Scan J Trauma Resusc Emerg Med. 2009;17:28.
64. Alejandria MM, Lansang MA, Dans LF, Mantaring JB. Intravenous immunoglobulin for treating sep-sis and septic shock. Cochrane Database Syst Rev. 2002:CD001090.
65. Lamothe F, D’Amico P, Ghosn P, et al. Clinical usefulness of intravenous human immunoglo- bulins in invasive group A Streptococcal infec-tions: case report and review. Clin Infect Dis. 1995;21:1469–1470.
66. Takei S, Arora YK, Walker SM. Intravenous im-munoglobulin contains specific antibodies inhi-bitory to activation of T cells by staphylococcal toxin superantigens. J Clin Invest. 1993;91:602–607.
67. Norrby-Teglund A, Kaul R, Low DE, et al. Plasma from patients with severe invasive group A streptococcal infections treated with normal po-lyspecific IgG inhibits streptococcal superanti-gen-induced T cell proliferation and cytokine production. J Immunol. 1996;156: 3057–3064.
68. Darabi K, Abdel-Wahab O, Dzik WH. Current usage of intravenous immune globulin and the rationale behind it : the Massachusetts General Hospital data and a review of the literature. Transfusion. 2006;46:741–753.
69. Schrage B, Duan G, Yang LP, et al. Different preparations of intravenous immunoglobulin vary in their efficacy to neutralize streptococcal su-perantigens: implications for treatment of strep-tococcal toxic shock syndrome. Clin Infect Dis. 2006;43:743–746.
70. Korhonen K. Hyperbaric oxygen therapy in acute necrotizing infections. With a special reference to the effects on tissue gas tensions. Ann Chir Gy-naecol. 2000;89:7–36.
71. Kaye D. Effect of hyperbaric oxygen on Clostridia in vitro and in vivo. Proc Soc Exp Biol Med. 1967;124:360–366.
72. Hill G, Osterhout S. Experimental effects of hy-perbaric oxygen on selected clostridial species. J Infect Dis. 1972;125:17–25.
73. Riseman JA, Zamboni WA, Curtis A, et al. Hy-perbaric oxygen therapy for necrotizing fasciitis reduces mortality and the need for debridements. Surgery. 1990;108:847–850.
74. Brown DR, Davis NL, Lepawsky M, et al. A mul-ticenter review of the treatment of major truncal necrotizing infections with and without hyperbaric oxygen therapy. Am J Surg. 1994;167: 485–489.
75. Shupak A, Shoshani O, Goldenberg I, et al. Ne-crotizing fasciitis: an indication for hyperbaric oxygenation therapy. Surgery. 1995;118:873–878.
76. Krieg A, Dizdar L, Verde PE, Knoefel WT. Pre-dictors of mortality for necrotizing soft-tissue infections: a retrospective analysis of 64 cases. Langenbeck’s Arch Surg. 2014; 399(3):333–341.
77. Audureau E, Hua C, de Prost N, Hemery F, De-cousser JW, Bosc R, Lepeule R, Chosidow O, Sbidian E.Mortality of necrotizing fasciitis: rela-tive influence of individual and hospital level factors, a nationwide multilevel study. Br J Der-matol. 2007;177(6):1575–1582.
78. Kao LS, Lew DF, Arab SN, Todd SR, Awad SS, Carrick MM, Corneille MG, Lally KP. Local varia-tions in the epidemiology, microbiology, and outcome of necrotizing soft-tissue infections: a multicenter study. Am J Surg. 2011; 202(2):139–145.
79. Nawijn F, Smeeing D P J, Houwert R M et al. Time is of the essence when treating necrotizing soft tissue infections: a systematic review and me-ta-analysis. World J Emerg Surg. 2020; 15, 4.
80. Cheng NC, Su YM, Kuo YS, Tai HC, Tang YB. Factors affecting the mortality of necrotizing fasciitis involving the upper extremities. Surg Today. 2008; 38(12):1108–1113.
81. Uehara K, Yasunaga H, Morizaki Y, Horiguchi H, Fushimi K, Tanaka S. Necrotising soft-tissue in-fections of the upper limb: risk factors for am-putation and death. Bone Jt J. 2014; 96B(11):1530–1534.
82. Nawijn F, Verhiel S H, Lunn K N et al. Factors Associated with Mortality and Amputation Caused by Necrotizing Soft Tissue Infections of the Upper Extremity: A Retrospective Cohort Study. World J Surg. 2020; 44, 730–740.
83. Ahn J, Raspovic K M, Liu G T, Lavery L A, Javier La Fontaine J, Nakonezny P A, Wukich D K. Lower Extremity Necrotizing Fasciitis in Diabetic and Nondiabetic Patients: Mortality and Amputation. Int J Low Extrem Wounds. 2019; 18(2):114-121.
84. Tang WM, Ho PL, Fung KK, Yuen KY, Leong JCY. Necrotising fasciitis of a limb. J Bone Jt Surg. 2001; 83(5):709–714.
85. Corona PS, Erimeiku F, Reverte´-Vinaixa MM, Soldado F, Amat C, Carrera L. Necrotising fascii-tis of the extremities: implementation of new management technologies. Injury. 2016; 47:S66–S71.
86. Ogilvie CM, Miclau T. Necrotizing soft tissue in-fections of the extremities and back. Clin Orthop Relat Res. 2006; 447:179–186.
87. Gonzalez M, Kay T, Weinzweig N, Brown A, Pul-virenti J. Necrotizing fasciitis of the upper extre-mity. J Hand Surg Am. 1966;21A:689–692.